32 results on '"Montefiori, David"'
Search Results
2. Stabilized trimeric peptide immunogens of the complete HIV-1 gp41 N-heptad repeat and their use as HIV-1 vaccine candidates.
3. Enhanced SIV Replication and Accelerated Progression to AIDS in Macaques Primed to Mount a CD4 T Cell Response to the SIV Envelope Protein
4. Recombinant Poxvirus Boosting of DNA-Primed Rhesus Monkeys Augments Peak but Not Memory T Lymphocyte Responses
5. Crosslinked HIV-1 Envelope-CD4 Receptor Complexes Elicit Broadly Cross-Reactive Neutralizing Antibodies in Rhesus Macaques
6. Structured Antiretroviral Treatment Interruptions in Chronically HIV-1-Infected Subjects
7. Augmentation of Immune Responses to HIV-1 and Simian Immunodeficiency Virus DNA Vaccines by IL-2/Ig Plasmid Administration in Rhesus Monkeys
8. Postexposure Immunoprophylaxis of Primary Isolates by an Antibody to HIV Receptor Complex
9. Potent, Protective Anti-HIV Immune Responses Generated by Bimodal HIV Envelope DNA Plus Protein Vaccination
10. Human Immunodeficiency Virus Type 1 Infection despite Prior Immunization with a Recombinant Envelope Vaccine Regimen
11. Envelope residue 375 substitutions in simian–human immunodeficiency viruses enhance CD4 binding and replication in rhesus macaques
12. Long antibody HCDR3s from HIV-naïve donors presented on a PG9 neutralizing antibody background mediate HIV neutralization
13. Balance of cellular and humoral immunity determines the level of protection by HIV vaccines in rhesus macaque models of HIV infection
14. Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgG
15. Most rhesus macaques infected with the CCR5-tropic SHIV AD8 generate cross-reactive antibodies that neutralize multiple HIV-1 strains
16. Vaccination with peptide mimetics of the gp41 prehairpin fusion intermediate yields neutralizing antisera against HIV-1 isolates
17. Prolonged exposure of the HIV-1 gp41 membrane proximal region with L669S substitution
18. DNA Vaccination in Rhesus Macaques Induces Potent Immune Responses and Decreases Acute and Chronic Viremia after SIVmac251 Challenge
19. Scaleable Manufacture of HIV-1 Entry Inhibitor Griffithsin and Validation of Its Safety and Efficacy as a Topical Microbicide Component
20. Identification and Characterization of Transmitted and Early Founder Virus Envelopes in Primary HIV-1 Infection
21. Role of Protein N-glycosylation in Pathogenesis of Human Immunodeficiency Virus Type 1
22. Antibody-Dependent Enhancement of Human Immunodeficiency Virus Type 1 (HIV-1) Infection in vitro by Serum from HIV-1-Infected and Passively Immunized Chimpanzees
23. Phosphorothioate and Cordycepin Analogues of 2′,5′-oligoadenylate: Inhibition of Human Immunodeficiency Virus Type 1 Reverse Transcriptase and Infection in vitro
24. Antiviral Activity of Mismatched Double-Stranded RNA against Human Immunodeficiency Virus in vitro
25. Inactivated Whole-Virus Vaccine Derived from a Proviral DNA Clone of Simian Immunodeficiency Virus Induces High Levels of Neutralizing Antibodies and Confers Protection Against Heterologous Challenge
26. Metabolite Gene Regulation of the L-Arabinose Operon in Escherichia coli with Indoleacetic Acid and Other Indole Derivatives
27. Most rhesus macaques infected with the CCR5-tropic SHIVAD8 generate cross-reactive antibodies that neutralize multiple HIV-1 strains.
28. Vaccination with peptide mimetics of the gp41 prehairpin fusion intermediate yields neutralizing antisera against HIV-1 isolates.
29. Prolonged exposure of the HIV-1 gp41 membrane proximal region with L669S substitution.
30. Stabilized trimeric peptide immunogens of the complete HIV-1 gp41 N-heptad repeat and their use as HIV-1 vaccine candidates.
31. Prevention efficacy of the broadly neutralizing antibody VRC01 depends on HIV-1 envelope sequence features.
32. Most rhesus macaques infected with the CCR5-tropic SHIV(AD8) generate cross-reactive antibodies that neutralize multiple HIV-1 strains.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.